We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.45B
AUM Growth
+$336M
Cap. Flow
+$603M
Cap. Flow %
41.48%
Top 10 Hldgs %
67.23%
Holding
768
New
375
Increased
70
Reduced
59
Closed
238

Top Buys

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$151M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$48.3M
3
ITOS
iTeos Therapeutics
ITOS
+$21.3M
4
QNGY
Quanergy Systems, Inc.
QNGY
+$11.5M
5
FULC icon
Fulcrum Therapeutics
FULC
+$10.9M

Top Sells

Rank Stock Value
1
SMH icon
VanEck Semiconductor ETF
SMH
+$30.8M
2
DIS icon
Walt Disney
DIS
+$23.1M
3
NGHC
National General Holdings Corp
NGHC
+$20.7M
4
STLA icon
Stellantis
STLA
+$19.7M
5
SVOKU
Seven Oaks Acquisition Corp. Unit
SVOKU
+$16M

Sector Composition

Rank Sector Weight
1 Healthcare 11.15%
2 Financials 9.75%
3 Technology 2.87%
4 Industrials 2.67%
5 Consumer Discretionary 1.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FFAI
401
CALL
Faraday Future Intelligent Electric
FFAI
$10.6M
– –
0
– –
CFIVW
402
DELISTED
CF Acquisition Corp. IV Warrant
CFIVW
$43K ﹤0.01%
+49,167
New +$62K
SIOX
403
PUT
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$43K ﹤0.01%
22,500
+3,500
+18% +$9.9K
HCIIW
404
DELISTED
Hudson Executive Investment Corp. II Warrant
HCIIW
$43K ﹤0.01%
+55,000
New +$52.3K
BAND
405
CALL
Bandwidth Inc
BAND
$1.66B
$42K ﹤0.01%
+7,400
New +$1.15M
RIGL icon
406
CALL
Rigel Pharmaceuticals
RIGL
$785M
$42K ﹤0.01%
7,840
+1,870
+31% +$74.1K
MRTX
407
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$42K ﹤0.01%
13,500
-46,100
-77% -$9.13M
RBAC.WS
408
DELISTED
RedBall Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordina
RBAC.WS
$42K ﹤0.01%
30,572
+5,572
+22% +$10.6K
HGEN
409
DELISTED
HUMANIGEN, INC.
HGEN
$40K ﹤0.01%
+2,097
New +$38.3K
GRNAW
410
DELISTED
GreenLight Biosciences Holdings, PBC Warrant
GRNAW
$40K ﹤0.01%
+46,234
New +$48.2K
ALNY icon
411
Alnylam Pharmaceuticals
ALNY
$29.6B
$38K ﹤0.01%
+268
New +$40.3K
NSTB.WS
412
DELISTED
Northern Star Investment Corp. II Redeemable warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTB.WS
$38K ﹤0.01%
+28,064
New +$51.7K
MUDSW
413
DELISTED
Mudrick Capital Acquisition Corporation II Warrant
MUDSW
$37K ﹤0.01%
+58,027
New +$58K
DXJ icon
414
PUT
WisdomTree Japan Hedged Equity Fund
DXJ
$7.43B
$36K ﹤0.01%
+12,100
New +$706K
CP icon
415
PUT
Canadian Pacific Kansas City
CP
$80.8B
$35K ﹤0.01%
+247,500
New +$17.8M
THS
416
CALL
DELISTED
Treehouse Foods
THS
$35K ﹤0.01%
+20,000
New +$946K
LUXAW
417
DELISTED
Lux Health Tech Acquisition Corp. Warrants
LUXAW
$35K ﹤0.01%
+23,657
New +$59.6K
DRNA
418
CALL
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$35K ﹤0.01%
+10,000
New +$255K
COEPW
419
DELISTED
Coeptis Therapeutics Warrants
COEPW
$34K ﹤0.01%
+78,675
New +$73.8K
CAP.WS
420
DELISTED
Capitol Investment Corp. V Warrants, each whole warrant exercisable for one share of Class A common
CAP.WS
$34K ﹤0.01%
+25,000
New +$36.9K
IONS icon
421
CALL
Ionis Pharmaceuticals
IONS
$9.21B
$33K ﹤0.01%
+40,300
New +$2.25M
KLAQW
422
DELISTED
KL Acquisition Corp Warrant
KLAQW
$33K ﹤0.01%
+51,364
New +$43.9K
BBIO icon
423
CALL
BridgeBio Pharma
BBIO
$16.4B
$32K ﹤0.01%
+21,000
New +$1.37M
AL
424
PUT
DELISTED
Air Lease Corp
AL
$31K ﹤0.01%
+21,100
New +$962K
TMTSW
425
DELISTED
Spartacus Acquisition Corporation Warrant
TMTSW
$31K ﹤0.01%
48,855
+8,855
+22% +$10.2K
15 16
17
18 19

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q1 2021 Portfolio in Review

As of Q1 2021, Cowen and Company held 768 positions worth $1.45B, up 30% from $1.12B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Cowen and Company deployed $603M of net new capital in Q1 2021, opening 375 new positions and adding to 70 existing holdings. Its largest new stake was iTeos Therapeutics: 588,238 shares worth $20.1M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 4.9% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Freeport-McMoran, an estimated $5.42M trimmed.

  • Cowen and Company's largest Q1 2021 buy was iTeos Therapeutics: 588,238 shares worth $20.1M.
  • Cowen and Company added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2021, an estimated $151M increase.
  • Cowen and Company's biggest Q1 2021 reduction was Freeport-McMoran, cutting an estimated $5.42M.
  • Cowen and Company fully exited VanEck Semiconductor ETF in Q1 2021, selling an estimated $30.8M.
  • Cowen and Company's ten largest holdings make up 67% of its $1.45B portfolio in Q1 2021.
  • Cowen and Company opened 375 new positions and closed 238 in Q1 2021.
  • Cowen and Company's portfolio value rose 30% quarter-over-quarter to $1.45B.

Based on Cowen and Company's 13F filing for Q1 2021, filed 4 May 2021.